|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA. |
| 公司地址
| Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174 |
| 電話號碼
| +34 935710500 |
| 傳真號碼
| +34 938008000 |
| 公司網頁
| https://www.grifols.com |
| 員工數量
| 23822 |
| Mr. Ignacio Ramal Subira |
Chief Internal Audit and Enterprise Risk Manager |
-- |
11/04/2025 |
| Mr. Jose Ignacio Abia Buenache |
Director and Chief Executive Officer |
-- |
11/04/2025 |
| Mr. Lluis Pons Gomez |
Senior Vice President, Strategy |
-- |
11/04/2025 |
| Ms. Montse Ribas |
Chief Communications and Reputation Officer |
-- |
11/04/2025 |
| Mr. Jordi Balsells Valls |
President, Plasma Procurement |
-- |
11/04/2025 |
| Ms. Laura de la Cruz Galan |
Vice Secretary |
-- |
11/04/2025 |
| Mr. Camille Alpi |
Chief Human Resources and Talent Officer |
-- |
11/04/2025 |
| Ms. Nuria Martin Barnes |
Secretary |
-- |
11/04/2025 |
| Mr. David Ian Bell |
General Counsel, Chief Corporate Affairs and Legal Officer |
-- |
11/04/2025 |
| Dr. Jorg Schuttrumpf |
Chief Scientific Innovation Officer |
-- |
11/04/2025 |
| Mr. Rahul Srinivasan |
Chief Financial Officer |
-- |
11/04/2025 |
| Mr. Daniel Fleta Coit |
Chief Industrial Services Officer |
-- |
11/04/2025 |
| Dr. Antonio Martinez Martinez |
President, Diagnostic |
-- |
11/04/2025 |
| Dr. Roland Wandeler, PhD |
President, Biopharma Business Unit |
-- |
11/04/2025 |
| Mr. Jaime Gonzalez Peralta |
Chief Digital Information Officer |
-- |
11/04/2025 |
| Mr. Enrique de la Torre |
Chief Compliance Officer |
-- |
11/04/2025 |
|
|
| Mr. Jose Ignacio Abia Buenache |
Director and Chief Executive Officer |
11/04/2025 |
| Ms. Susana Gonzalez Rodriguez |
Independent Director |
11/04/2025 |
| Mr. Thomas H. Glanzmann |
Executive Chairman of the Board |
11/04/2025 |
| Mr. Paul S. Herendeen |
Director |
11/04/2025 |
| Ms. Montserrat Munoz Abellana |
Lead Independent Director |
11/04/2025 |
| Ms. Anne-Catherine Berner |
Independent Director |
11/04/2025 |
| Mr. Tomas Daga Gelabert |
Director |
11/04/2025 |
| Mr. Raimon Grifols Roura |
Vice Chairman of the Board |
11/04/2025 |
| Mr. Inigo Sanchez-Asiain Mardones |
Independent Director |
11/04/2025 |
| Mr. Víctor Grifols Deu |
Director |
11/04/2025 |
| Mr. Pascal Ravery |
Independent Director |
11/04/2025 |
| Mr. Albert Grifols Coma-Cros |
Director |
11/04/2025 |
| Ms. Enriqueta Felip Font |
Independent Director |
11/04/2025 |
|
|
|
|
